首页 > 最新文献

Journal of Medical Case Reports最新文献

英文 中文
Scrub typhus with hemorrhagic stroke: a case report. 恙虫病合并出血性中风:病例报告。
IF 0.9 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-07-27 DOI: 10.1186/s13256-024-04667-0
Om Prakash Bhatta, Sabita Chand, Hemant Chand, Prashant Bhetwal, Sachin Awasthi, Aruna Acharya, Ram Chandra Poudel

Background: Scrub typhus, caused by Orientia tsutsugamushi, rarely leads to central nervous system involvement. Although intracerebral bleeding is rare due to endemicity and a significant proportion of underdiagnoses, it should be considered a noteworthy differential diagnosis in endemic regions in patients with relevant history and clinical findings.

Case presentation: We present the case of a 40-year-old Nepali woman who visited the emergency department with complaints of left-sided weakness for 6 hours and an acute febrile illness with an eschar for 7 days and was diagnosed with scrub typhus by immunoglobulin M enzyme-linked immunosorbent assay of the serum. Imaging revealed a right-sided frontotemporal hematoma, and further examination revealed pulmonary edema with multiple organ dysfunction syndrome. The patient was mechanically ventilated and was treated with antibiotics, steroids, vasopressors, and antipyretics. However, the hematoma was treated conservatively, with ongoing neurological recovery at the 6-month follow-up.

Conclusion: Although neurological complications and intracranial hemorrhage are uncommon, physicians must be cautious when making differential diagnoses and initiating appropriate therapies to avoid serious or fatal complications.

背景:由恙虫病原虫引起的恙虫病很少导致中枢神经系统受累。尽管脑出血因其流行性和大量漏诊而罕见,但在流行地区,对于有相关病史和临床表现的患者,脑出血应被视为值得注意的鉴别诊断:本病例是一名 40 岁的尼泊尔妇女,因主诉左侧肢体无力 6 小时、急性发热伴脓肿 7 天而就诊于急诊科,经血清免疫球蛋白 M 酶联免疫吸附试验确诊为恙虫病。影像学检查发现右侧额颞部血肿,进一步检查发现肺水肿伴有多器官功能障碍综合征。患者接受了机械通气,并接受了抗生素、类固醇、血管加压剂和退烧药治疗。然而,血肿得到了保守治疗,随访6个月后神经功能持续恢复:尽管神经系统并发症和颅内出血并不常见,但医生在进行鉴别诊断和采取适当治疗时必须谨慎,以避免出现严重或致命的并发症。
{"title":"Scrub typhus with hemorrhagic stroke: a case report.","authors":"Om Prakash Bhatta, Sabita Chand, Hemant Chand, Prashant Bhetwal, Sachin Awasthi, Aruna Acharya, Ram Chandra Poudel","doi":"10.1186/s13256-024-04667-0","DOIUrl":"10.1186/s13256-024-04667-0","url":null,"abstract":"<p><strong>Background: </strong>Scrub typhus, caused by Orientia tsutsugamushi, rarely leads to central nervous system involvement. Although intracerebral bleeding is rare due to endemicity and a significant proportion of underdiagnoses, it should be considered a noteworthy differential diagnosis in endemic regions in patients with relevant history and clinical findings.</p><p><strong>Case presentation: </strong>We present the case of a 40-year-old Nepali woman who visited the emergency department with complaints of left-sided weakness for 6 hours and an acute febrile illness with an eschar for 7 days and was diagnosed with scrub typhus by immunoglobulin M enzyme-linked immunosorbent assay of the serum. Imaging revealed a right-sided frontotemporal hematoma, and further examination revealed pulmonary edema with multiple organ dysfunction syndrome. The patient was mechanically ventilated and was treated with antibiotics, steroids, vasopressors, and antipyretics. However, the hematoma was treated conservatively, with ongoing neurological recovery at the 6-month follow-up.</p><p><strong>Conclusion: </strong>Although neurological complications and intracranial hemorrhage are uncommon, physicians must be cautious when making differential diagnoses and initiating appropriate therapies to avoid serious or fatal complications.</p>","PeriodicalId":16236,"journal":{"name":"Journal of Medical Case Reports","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2024-07-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11282747/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141766250","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Superficial temporal artery aneurysm misdiagnosed in a patient with long-term migraine headache treatment: a case report. 一名长期接受偏头痛治疗的患者被误诊为颞浅动脉瘤:病例报告。
IF 0.9 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-07-26 DOI: 10.1186/s13256-024-04647-4
Meghdad Ghasemi Gorji, Ali Rafiei, Amirhossein Rajabi

Background: Superficial temporal artery aneurysm is a rare vascular abnormality without specific clinical symptoms. In this case report, we present the case of a patient with superficial temporal artery aneurysm who was diagnosed with migraine headache at first.

Case presentation: A 60-year-old Iranian man with a previous history of headaches, who did not respond properly to the treatments following the initial diagnosis of migraine, presented with a painless lump in the left temporal region, and he was diagnosed with superficial temporal artery aneurysm via Doppler ultrasound. Finally, surgical removal of the left superficial temporal artery aneurysm was performed.

Conclusions: This case shows the importance of vascular causes in the approach to headache etiologies, especially when the headache is prolonged without proper responses to treatment. Computed tomography angiography and magnetic resonance angiography are appropriate diagnostic methods for aneurysm detection that should be considered in future studies.

背景:颞浅动脉瘤是一种罕见的血管畸形,没有特殊的临床症状。在本病例报告中,我们介绍了一名颞浅动脉瘤患者的病例,该患者最初被诊断为偏头痛:一名 60 岁的伊朗男子既往有头痛病史,最初被诊断为偏头痛后治疗效果不佳,后来出现左侧颞部无痛肿块,通过多普勒超声检查被诊断为颞浅动脉瘤。最后,手术切除了左侧颞浅动脉瘤:本病例显示了血管病因在头痛病因治疗中的重要性,尤其是当头痛持续时间较长而治疗效果不佳时。计算机断层扫描血管造影术和磁共振血管造影术是检测动脉瘤的适当诊断方法,应在今后的研究中加以考虑。
{"title":"Superficial temporal artery aneurysm misdiagnosed in a patient with long-term migraine headache treatment: a case report.","authors":"Meghdad Ghasemi Gorji, Ali Rafiei, Amirhossein Rajabi","doi":"10.1186/s13256-024-04647-4","DOIUrl":"10.1186/s13256-024-04647-4","url":null,"abstract":"<p><strong>Background: </strong>Superficial temporal artery aneurysm is a rare vascular abnormality without specific clinical symptoms. In this case report, we present the case of a patient with superficial temporal artery aneurysm who was diagnosed with migraine headache at first.</p><p><strong>Case presentation: </strong>A 60-year-old Iranian man with a previous history of headaches, who did not respond properly to the treatments following the initial diagnosis of migraine, presented with a painless lump in the left temporal region, and he was diagnosed with superficial temporal artery aneurysm via Doppler ultrasound. Finally, surgical removal of the left superficial temporal artery aneurysm was performed.</p><p><strong>Conclusions: </strong>This case shows the importance of vascular causes in the approach to headache etiologies, especially when the headache is prolonged without proper responses to treatment. Computed tomography angiography and magnetic resonance angiography are appropriate diagnostic methods for aneurysm detection that should be considered in future studies.</p>","PeriodicalId":16236,"journal":{"name":"Journal of Medical Case Reports","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2024-07-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11274752/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141759250","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of exercise on cluneal nerve entrapment neuropathy: a case report. 运动对锁骨神经卡压性神经病的影响:病例报告。
IF 0.9 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-07-25 DOI: 10.1186/s13256-024-04641-w
Burcu Özüberk, Mine Argalı Deniz, Feray Cinevre Soyupek

Background: Low back pain is an important disability problem frequently encountered in the clinic. In the literature, it has been shown that neuropathic pain in chronic low back pain is quite common in patients. Although superior cluneal nerve entrapment syndrome is an underdiagnosed cause of low back and leg pain, differential diagnosis is very important anatomically and clinically. The superior cluneal nerves are pure sensory nerves that innervate the skin of the upper part of the buttocks. In the literature, methods such as surgery, nerve blockade, prolotherapy, and acupuncture have been used in the treatment of cluneal nerve entrapment syndrome, but there are no studies on exercise. In this case report, our aim is to explain the importance of differential diagnosis in cluneal nerve entrapment syndrome, which is one of the common causes of low back pain in the clinic, and the effects of exercise in this disease.

Case presentation: A 22-year-old, Turkish-ethnicity, male patient with complaints of low back pain, neck-back pain, and weakness did not use alcohol or cigarettes. In his family history, there was a history of diabetes in the mother and diabetes and heart failure in the father. He had a history of osteoporosis, epilepsy, asthma, sarcoidosis, and cardiac arrhythmia. The patient reported that he suffered from constipation three to four times a month. As a result of the detailed evaluation, the planned exercise prescription was taught to the patient, and after it was confirmed that the patient did the exercises correctly for 3 days, the exercise brochure was given and followed as a home exercise program for 8 weeks.

Conclusions: Lumbar stabilization exercises, gluteal muscle strengthening exercises, thoracolumbar fascia mobilization, and stretching exercises, which will be given in accordance with the clinical anatomy of the disease after the correct diagnosis in cluneal nerve entrapment syndrome, have been beneficial for the patient. However, we think that randomized controlled studies with a large sample will contribute to the literature.

背景:腰背痛是临床上经常遇到的重要残疾问题。文献显示,慢性腰痛患者中神经病理性疼痛相当常见。虽然锁骨上神经卡压综合征是腰腿痛的一个诊断不足的病因,但在解剖学和临床上,鉴别诊断非常重要。臀上神经是支配臀部上部皮肤的纯感觉神经。在文献中,手术、神经阻滞、增生疗法和针灸等方法已被用于治疗锁骨上神经卡压综合征,但还没有关于运动的研究。在本病例报告中,我们的目的是解释阉割神经卡压综合征(临床上腰痛的常见原因之一)鉴别诊断的重要性,以及运动对该病的影响:一名 22 岁的土耳其裔男性患者,主诉腰背痛、颈背痛和乏力,不酗酒也不抽烟。在他的家族史中,母亲有糖尿病史,父亲有糖尿病和心力衰竭史。他有骨质疏松症、癫痫、哮喘、肉瘤病和心律失常病史。患者称,他每个月都会便秘三到四次。经过详细评估后,向患者传授了计划中的运动处方,并在确认患者正确做了 3 天运动后,向其发放了运动手册,作为为期 8 周的家庭运动计划:结论:腰椎稳定运动、臀肌强化运动、胸腰筋膜活动和伸展运动,在正确诊断克鲁纳尔神经卡压综合征后,根据疾病的临床解剖学给予这些运动,对患者有益。但我们认为,大样本的随机对照研究将有助于文献的研究。
{"title":"Effect of exercise on cluneal nerve entrapment neuropathy: a case report.","authors":"Burcu Özüberk, Mine Argalı Deniz, Feray Cinevre Soyupek","doi":"10.1186/s13256-024-04641-w","DOIUrl":"10.1186/s13256-024-04641-w","url":null,"abstract":"<p><strong>Background: </strong>Low back pain is an important disability problem frequently encountered in the clinic. In the literature, it has been shown that neuropathic pain in chronic low back pain is quite common in patients. Although superior cluneal nerve entrapment syndrome is an underdiagnosed cause of low back and leg pain, differential diagnosis is very important anatomically and clinically. The superior cluneal nerves are pure sensory nerves that innervate the skin of the upper part of the buttocks. In the literature, methods such as surgery, nerve blockade, prolotherapy, and acupuncture have been used in the treatment of cluneal nerve entrapment syndrome, but there are no studies on exercise. In this case report, our aim is to explain the importance of differential diagnosis in cluneal nerve entrapment syndrome, which is one of the common causes of low back pain in the clinic, and the effects of exercise in this disease.</p><p><strong>Case presentation: </strong>A 22-year-old, Turkish-ethnicity, male patient with complaints of low back pain, neck-back pain, and weakness did not use alcohol or cigarettes. In his family history, there was a history of diabetes in the mother and diabetes and heart failure in the father. He had a history of osteoporosis, epilepsy, asthma, sarcoidosis, and cardiac arrhythmia. The patient reported that he suffered from constipation three to four times a month. As a result of the detailed evaluation, the planned exercise prescription was taught to the patient, and after it was confirmed that the patient did the exercises correctly for 3 days, the exercise brochure was given and followed as a home exercise program for 8 weeks.</p><p><strong>Conclusions: </strong>Lumbar stabilization exercises, gluteal muscle strengthening exercises, thoracolumbar fascia mobilization, and stretching exercises, which will be given in accordance with the clinical anatomy of the disease after the correct diagnosis in cluneal nerve entrapment syndrome, have been beneficial for the patient. However, we think that randomized controlled studies with a large sample will contribute to the literature.</p>","PeriodicalId":16236,"journal":{"name":"Journal of Medical Case Reports","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2024-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11270947/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141759249","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Usability of a novel Hounsfield units measurement procedure to quantify intercorporal bone graft remodeling in patients after posterior lumbar interbody fusion: a case series. 用新型 Hounsfield 单位测量程序量化腰椎后路椎体间融合术后患者椎体间植骨重塑的可用性:病例系列。
IF 0.9 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-07-24 DOI: 10.1186/s13256-024-04655-4
Joey F H Reijmer, Job L C van Susante, Moyo C Kruijt, Maarten J van Gorp, Lex D de Jong

Background: There is a lack of knowledge about the biological process of intercorporal bone graft remodeling after posterior lumbar interbody fusion surgery and whether this process is associated with changes in back pain and intercorporal fusion status. As an alternative to the commonly used but unreliable fusion criteria, Hounsfield units can be used to quantify biological activity and changes in bone mineral content. However, studies assessing Hounsfield units conducted to date do not provide sufficient details about how the bone grafts were segmented to measure the Hounsfield units to allow for replication, and did not assess individual patient trends in graft changes over time. Using the data of nine patients after posterior lumbar interbody fusion, a novel Hounsfield units measurement procedure was developed and used to explore its usability to quantify the bone graft remodeling process.

Case details: We report a case series of nine patients (six male, three female, mean age 64 years, all Caucasian) who all had computed tomography scans performed at 1 and 2 years after posterior lumbar interbody fusion surgery. Overall, seven out of the nine (78%) cases had a 3-41% increase in their bone grafts' Hounsfield units between 1 and 2 years after surgery. The cases showed large interindividual variability in their Hounsfield units values over time, which coincided with varying levels of back pain and intercorporal fusion status.

Conclusion: The Hounsfield units measurement procedure used for this case series may be useful to quantify intercorporal bone graft remodeling in patients after posterior lumbar interbody fusion, and may be used as an adjunct diagnostic measure to monitor bone graft remodeling over time. Future research is warranted to explore how to interpret bone graft Hounsfield units-values and Hounsfield units trajectories in light of clinical variables or intercorporal fusion status.

背景:对于腰椎后路椎体间融合手术后椎体间植骨重塑的生物学过程,以及这一过程是否与腰痛和椎体间融合状态的变化相关,目前还缺乏了解。作为常用但不可靠的融合标准的替代方法,Hounsfield 单位可用于量化生物活性和骨矿物质含量的变化。然而,迄今为止进行的评估 Hounsfield 单位的研究并没有提供足够详细的信息,说明如何分割骨移植物以测量 Hounsfield 单位,从而进行复制,而且也没有评估个别患者的移植物随时间变化的趋势。利用腰椎后路椎体间融合术后九名患者的数据,我们开发了一种新的 Hounsfield 单位测量程序,并利用该程序探讨了量化植骨重塑过程的可用性:我们报告了九名患者(六名男性,三名女性,平均年龄 64 岁,均为白种人)的系列病例,他们均在腰椎后路椎体间融合术后 1 年和 2 年接受了计算机断层扫描。总体而言,9 个病例中有 7 个病例(78%)在术后 1 到 2 年间,移植物骨的 Hounsfield 单位增加了 3-41%。随着时间的推移,这些病例的 Hounsfield 单位值显示出很大的个体差异,这与不同程度的背痛和椎体间融合状况相吻合:结论:本病例系列中使用的 Hounsfield 单位测量程序可用于量化腰椎后路椎体间融合术后患者的椎体间植骨重塑情况,并可作为一种辅助诊断方法,监测植骨随着时间推移的重塑情况。未来的研究需要探索如何根据临床变量或椎间融合状态来解释植骨 Hounsfield 单位值和 Hounsfield 单位轨迹。
{"title":"Usability of a novel Hounsfield units measurement procedure to quantify intercorporal bone graft remodeling in patients after posterior lumbar interbody fusion: a case series.","authors":"Joey F H Reijmer, Job L C van Susante, Moyo C Kruijt, Maarten J van Gorp, Lex D de Jong","doi":"10.1186/s13256-024-04655-4","DOIUrl":"10.1186/s13256-024-04655-4","url":null,"abstract":"<p><strong>Background: </strong>There is a lack of knowledge about the biological process of intercorporal bone graft remodeling after posterior lumbar interbody fusion surgery and whether this process is associated with changes in back pain and intercorporal fusion status. As an alternative to the commonly used but unreliable fusion criteria, Hounsfield units can be used to quantify biological activity and changes in bone mineral content. However, studies assessing Hounsfield units conducted to date do not provide sufficient details about how the bone grafts were segmented to measure the Hounsfield units to allow for replication, and did not assess individual patient trends in graft changes over time. Using the data of nine patients after posterior lumbar interbody fusion, a novel Hounsfield units measurement procedure was developed and used to explore its usability to quantify the bone graft remodeling process.</p><p><strong>Case details: </strong>We report a case series of nine patients (six male, three female, mean age 64 years, all Caucasian) who all had computed tomography scans performed at 1 and 2 years after posterior lumbar interbody fusion surgery. Overall, seven out of the nine (78%) cases had a 3-41% increase in their bone grafts' Hounsfield units between 1 and 2 years after surgery. The cases showed large interindividual variability in their Hounsfield units values over time, which coincided with varying levels of back pain and intercorporal fusion status.</p><p><strong>Conclusion: </strong>The Hounsfield units measurement procedure used for this case series may be useful to quantify intercorporal bone graft remodeling in patients after posterior lumbar interbody fusion, and may be used as an adjunct diagnostic measure to monitor bone graft remodeling over time. Future research is warranted to explore how to interpret bone graft Hounsfield units-values and Hounsfield units trajectories in light of clinical variables or intercorporal fusion status.</p>","PeriodicalId":16236,"journal":{"name":"Journal of Medical Case Reports","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2024-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11267840/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141751880","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A differential expression of an identical mutation in CYP17A1 gene in two infertility patients: a case report. 两个不孕症患者 CYP17A1 基因相同突变的差异表达:病例报告。
IF 0.9 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-07-23 DOI: 10.1186/s13256-024-04654-5
Elay Rabinovich, Anat Hershko-Klement, Yaakov Bentov

Background: 17-Hydroxylase deficiency is the rarest form of congenital adrenal hyperplasia, a disorder that affects steroidogenesis, causing abnormal hormone levels. Studies have shown a clear association between 17-hydroxylase deficiency and primary infertility, but a definite protocol to treat the disorder has not been determined yet.

Case presentation: Case I presents a 24-year-old Caucasian Israeli-Arab female who experienced 6 years of infertility. Before her initial visit to our clinic, she underwent three laparoscopic ovarian cystectomies, had an unsuccessful in vitro fertilization cycle, and was treated with combined oral contraceptives. Her hormonal profile was tested, and the results led to genetic counseling and the diagnosis of non-classical congenital adrenal hyperplasia. She was treated with estradiol, glucocorticoids, and transdermal testosterone. After hormonal levels were lowered, in vitro fertilization cycles were initiated, and the patient had a spontaneous ovulation. In case II, a 20-year-old Caucasian Israeli-Arab female presented for infertility evaluation owing to her oligomenorrhea. Her vitals and physical examination had normal results. The investigation of her abnormal hormonal profile led her to be referred to genetic testing, where the results showed the same genetic mutation as seen in case I.

Conclusion: Both cases highlight the distinctiveness of the condition, where an identical mutation in the gene responsible for the same enzyme can bring about diverse phenotypes. Case I offers a potential treatment protocol for this rare disorder.

背景:17-羟化酶缺乏症是最罕见的先天性肾上腺皮质增生症,这种疾病会影响类固醇的生成,导致激素水平异常。研究表明,17-羟化酶缺乏症与原发性不孕症之间存在明显的关联,但目前尚未确定治疗该疾病的明确方案:病例 I 是一名 24 岁的高加索裔以色列-阿拉伯女性,她经历了长达 6 年的不孕。在首次来我院就诊之前,她接受了三次腹腔镜卵巢囊肿切除术,试管受精周期失败,并接受了联合口服避孕药治疗。我们对她的荷尔蒙谱进行了检测,结果显示她需要接受遗传咨询,并被诊断为非典型性先天性肾上腺皮质增生症。她接受了雌二醇、糖皮质激素和透皮睾酮治疗。激素水平降低后,开始了体外受精周期,患者自然排卵。在病例二中,一名 20 岁的高加索裔以色列-阿拉伯女性因少经前来进行不孕症评估。她的生命体征和身体检查结果正常。在对她的异常荷尔蒙特征进行调查后,她被转介到基因检测中心,结果显示与病例 I 相同的基因突变:结论:这两个病例都突出了这种疾病的独特性,即负责同一种酶的基因发生了相同的突变,却会导致不同的表型。病例 I 为这种罕见疾病提供了一种潜在的治疗方案。
{"title":"A differential expression of an identical mutation in CYP17A1 gene in two infertility patients: a case report.","authors":"Elay Rabinovich, Anat Hershko-Klement, Yaakov Bentov","doi":"10.1186/s13256-024-04654-5","DOIUrl":"10.1186/s13256-024-04654-5","url":null,"abstract":"<p><strong>Background: </strong>17-Hydroxylase deficiency is the rarest form of congenital adrenal hyperplasia, a disorder that affects steroidogenesis, causing abnormal hormone levels. Studies have shown a clear association between 17-hydroxylase deficiency and primary infertility, but a definite protocol to treat the disorder has not been determined yet.</p><p><strong>Case presentation: </strong>Case I presents a 24-year-old Caucasian Israeli-Arab female who experienced 6 years of infertility. Before her initial visit to our clinic, she underwent three laparoscopic ovarian cystectomies, had an unsuccessful in vitro fertilization cycle, and was treated with combined oral contraceptives. Her hormonal profile was tested, and the results led to genetic counseling and the diagnosis of non-classical congenital adrenal hyperplasia. She was treated with estradiol, glucocorticoids, and transdermal testosterone. After hormonal levels were lowered, in vitro fertilization cycles were initiated, and the patient had a spontaneous ovulation. In case II, a 20-year-old Caucasian Israeli-Arab female presented for infertility evaluation owing to her oligomenorrhea. Her vitals and physical examination had normal results. The investigation of her abnormal hormonal profile led her to be referred to genetic testing, where the results showed the same genetic mutation as seen in case I.</p><p><strong>Conclusion: </strong>Both cases highlight the distinctiveness of the condition, where an identical mutation in the gene responsible for the same enzyme can bring about diverse phenotypes. Case I offers a potential treatment protocol for this rare disorder.</p>","PeriodicalId":16236,"journal":{"name":"Journal of Medical Case Reports","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2024-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11265429/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141748433","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A rare case of trigeminal trophic syndrome with periorbital cellulitis and full-thickness upper eyelid defect in an undiagnosed patient with human immunodeficiency virus: a case report. 一例罕见的三叉神经营养综合征伴眶周蜂窝织炎和全厚上眼睑缺损病例:病例报告,患者未确诊为人类免疫缺陷病毒感染者。
IF 0.9 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-07-22 DOI: 10.1186/s13256-024-04621-0
Stephen Apanga, Mohammed Alhassan, Bawa Abdulai

Background: Trigeminal trophic syndrome is a rare cranial and facial condition caused by damage to the central or peripheral branches of the trigeminal nerve. This syndrome consists of a triad of anesthesia, paresthesia, and crescent-shaped facial ulcer involving the ala nasi and sometimes extending to the upper lip. Although previous screening for human immunodeficiency virus in some patients with trigeminal trophic syndrome was negative, we present a unique case of trigeminal trophic syndrome who tested positive for human immunodeficiency virus with eye complications.

Case presentation: We present a rare case of trigeminal trophic syndrome in a 44-year-old Black African woman who tested positive for human immunodeficiency virus. She presented with a 6-week history of progressive, persistent, and painless left sided facial and scalp ulcerations that started as small skin erosion. Diagnosis of trigeminal trophic syndrome was made on clinical grounds based on the triad of anesthesia, paresthesia, and unilateral crescent-shaped ulcer in the trigeminal dermatome and her past medical history. The ulcer healed completely after counseling and pharmacological therapy, but she later developed left periorbital cellulitis and left upper eyelid full-thickness defect.

Conclusion: This is by far the first documented case of trigeminal trophic syndrome with a positive human immunodeficiency virus test. Testing for human immunodeficiency virus in patients with trigeminal trophic syndrome is necessary as this can help improve clinical management and treatment outcomes. Seeking the services of specialists remotely in resource constraint settings is beneficial for managing complications associated with trigeminal trophic syndrome.

背景:三叉神经营养综合征是一种罕见的颅面部疾病,由三叉神经中枢或外周分支受损引起。三叉神经营养不良综合征是一种罕见的颅面部疾病,由三叉神经中枢或外周分支受损引起,患者会出现麻醉、麻痹和新月形面部溃疡三联征,溃疡累及鼻翼,有时可延伸至上唇。尽管之前对一些三叉神经营养不良综合征患者进行的人类免疫缺陷病毒筛查呈阴性,但我们发现了一例独特的三叉神经营养不良综合征患者,其人类免疫缺陷病毒检测呈阳性,并伴有眼部并发症:我们报告了一例罕见的三叉神经营养不良综合征病例,患者是一名 44 岁的非洲黑人妇女,人类免疫缺陷病毒检测呈阳性。她因左侧面部和头皮出现进行性、持续性、无痛性溃疡已有 6 周病史,溃疡最初为小面积皮肤糜烂。根据三叉神经皮层的麻醉、麻痹和单侧新月形溃疡三联征及其既往病史,临床诊断为三叉神经营养不良综合征。经过心理辅导和药物治疗后,溃疡完全愈合,但她后来又患上了左眶周蜂窝织炎和左上眼睑全层缺损:结论:这是迄今为止记录在案的第一例人类免疫缺陷病毒检测呈阳性的三叉神经营养不良综合征病例。有必要对三叉神经营养不良综合征患者进行人类免疫缺陷病毒检测,因为这有助于改善临床管理和治疗效果。在资源有限的情况下,远程寻求专家服务有利于控制三叉神经营养不良综合征的相关并发症。
{"title":"A rare case of trigeminal trophic syndrome with periorbital cellulitis and full-thickness upper eyelid defect in an undiagnosed patient with human immunodeficiency virus: a case report.","authors":"Stephen Apanga, Mohammed Alhassan, Bawa Abdulai","doi":"10.1186/s13256-024-04621-0","DOIUrl":"10.1186/s13256-024-04621-0","url":null,"abstract":"<p><strong>Background: </strong>Trigeminal trophic syndrome is a rare cranial and facial condition caused by damage to the central or peripheral branches of the trigeminal nerve. This syndrome consists of a triad of anesthesia, paresthesia, and crescent-shaped facial ulcer involving the ala nasi and sometimes extending to the upper lip. Although previous screening for human immunodeficiency virus in some patients with trigeminal trophic syndrome was negative, we present a unique case of trigeminal trophic syndrome who tested positive for human immunodeficiency virus with eye complications.</p><p><strong>Case presentation: </strong>We present a rare case of trigeminal trophic syndrome in a 44-year-old Black African woman who tested positive for human immunodeficiency virus. She presented with a 6-week history of progressive, persistent, and painless left sided facial and scalp ulcerations that started as small skin erosion. Diagnosis of trigeminal trophic syndrome was made on clinical grounds based on the triad of anesthesia, paresthesia, and unilateral crescent-shaped ulcer in the trigeminal dermatome and her past medical history. The ulcer healed completely after counseling and pharmacological therapy, but she later developed left periorbital cellulitis and left upper eyelid full-thickness defect.</p><p><strong>Conclusion: </strong>This is by far the first documented case of trigeminal trophic syndrome with a positive human immunodeficiency virus test. Testing for human immunodeficiency virus in patients with trigeminal trophic syndrome is necessary as this can help improve clinical management and treatment outcomes. Seeking the services of specialists remotely in resource constraint settings is beneficial for managing complications associated with trigeminal trophic syndrome.</p>","PeriodicalId":16236,"journal":{"name":"Journal of Medical Case Reports","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2024-07-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11265085/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141734343","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Primary leiomyosarcoma of epididymis: a case report. 附睾原发性良性肉瘤:病例报告。
IF 0.9 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-07-21 DOI: 10.1186/s13256-024-04660-7
Hong-Jie Chen, Yao-Dong Han, Dong-Hai Li, Wu Li, Jun Zhang

Background: Leiomyosarcoma is a tumor that can develop in any organ that contains smooth muscles. Although leiomyosarcoma is common, its epididymal localization is quite rare.

Case presentation: A 79-year-old male Chinese Han patient presented with mild pain in the right groin and scrotum for 3 years concomitant with right scrotal swelling. Ultrasonography and magnetic resonance imaging of the scrotum showed a irregular and heterogeneous mass that was extratesticular. Right high orchiectomy was performed, and pathological examination of the resected specimen confirmed the diagnosis of leiomyosarcoma of the epididymis with surgical margins clear of tumor.

Conclusion: Epididymal leiomyosarcoma is rare and difficult to diagnose preoperatively. The final diagnosis of epididymal leiomyosarcoma requires histologic examination. Resection must be extensive and complete. The effect of chemotherapy and radiation on the epididymal leiomyosarcoma remains unclear. Recurrence is common, so follow-up is necessary.

背景介绍平滑肌肉瘤是一种可发生在任何含有平滑肌的器官中的肿瘤。虽然子宫线肉瘤很常见,但其附睾定位却相当罕见:一名 79 岁的中国汉族男性患者因右腹股沟和阴囊轻微疼痛 3 年,同时伴有右侧阴囊肿胀而就诊。阴囊超声波检查和磁共振成像显示阴囊外有一不规则的异型肿块。患者接受了右侧高位睾丸切除术,切除标本的病理检查确诊为附睾良性肉瘤,手术切缘无肿瘤:结论:附睾亮肌肉瘤非常罕见,术前诊断困难。附睾亮肌肉瘤的最终诊断需要组织学检查。切除必须广泛而彻底。化疗和放疗对附睾亮肌肉瘤的影响尚不明确。复发很常见,因此有必要进行随访。
{"title":"Primary leiomyosarcoma of epididymis: a case report.","authors":"Hong-Jie Chen, Yao-Dong Han, Dong-Hai Li, Wu Li, Jun Zhang","doi":"10.1186/s13256-024-04660-7","DOIUrl":"10.1186/s13256-024-04660-7","url":null,"abstract":"<p><strong>Background: </strong>Leiomyosarcoma is a tumor that can develop in any organ that contains smooth muscles. Although leiomyosarcoma is common, its epididymal localization is quite rare.</p><p><strong>Case presentation: </strong>A 79-year-old male Chinese Han patient presented with mild pain in the right groin and scrotum for 3 years concomitant with right scrotal swelling. Ultrasonography and magnetic resonance imaging of the scrotum showed a irregular and heterogeneous mass that was extratesticular. Right high orchiectomy was performed, and pathological examination of the resected specimen confirmed the diagnosis of leiomyosarcoma of the epididymis with surgical margins clear of tumor.</p><p><strong>Conclusion: </strong>Epididymal leiomyosarcoma is rare and difficult to diagnose preoperatively. The final diagnosis of epididymal leiomyosarcoma requires histologic examination. Resection must be extensive and complete. The effect of chemotherapy and radiation on the epididymal leiomyosarcoma remains unclear. Recurrence is common, so follow-up is necessary.</p>","PeriodicalId":16236,"journal":{"name":"Journal of Medical Case Reports","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2024-07-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11264998/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141734344","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Radiotherapy for subependymal giant cell astrocytoma: time to challenge a historical ban? A case report and review of the literature. 独立绒毛膜下巨细胞星形细胞瘤的放射治疗:是时候挑战历史禁令了吗?病例报告和文献综述。
IF 0.9 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-07-20 DOI: 10.1186/s13256-024-04649-2
Randa Kamel, Dirk Van den Berge

Background: Subependymal giant cell astrocytoma is a benign brain tumor that occurs in patients with tuberous sclerosis complex. Surgical removal is the traditional treatment, and expert opinion is strongly against the use of radiotherapy. Recently, success has been reported with the mTor inhibitor everolimus in reducing tumor volume, but regrowth has been observed after dose reduction or cessation.

Case report: We present the case of a 40-year-old Asian female patient treated successfully for growing bilateral subependymal giant cell astrocytoma with fractionated stereotactic radiotherapy before everolimus became available. After a follow-up of 8 years, everolimus was administered for renal angiomyolipoma and the patient was followed up until 13 years after radiotherapy. Successive magnetic resonance imaging demonstrated an 80% volume reduction after radiotherapy that increased to 90% with everolimus. A review of the literature was done leveraging Medline via PubMed, and we assembled a database of 1298 article references and 780 full-text articles in search of evidence for contraindicating radiotherapy in subependymal giant cell astrocytoma. Varying results of single-fraction radiosurgery were described in a total of 13 cases. Only in two published cases was the radiation dose of fractionated radiotherapy mentioned. One single publication mentions an induced secondary brain tumor 8 years after whole-brain radiotherapy.

Conclusion: There is no evidence of contraindication and exclusion of fractionated radiotherapy in treating subependymal giant cell astrocytoma. Our experience demonstrates that subependymal giant cell astrocytoma, as other benign intracranial tumors, responds slowly but progressively to radiotherapy and suggests that fractionated stereotactic radiotherapy holds promise to consolidate responses obtained with mTor inhibitors avoiding regrowth after cessation.

背景:脐下巨细胞星形细胞瘤是一种良性脑肿瘤,好发于结节性硬化症综合征患者。手术切除是传统的治疗方法,专家强烈反对使用放疗。最近,有报道称mTor抑制剂依维莫司在缩小肿瘤体积方面取得了成功,但在减量或停药后又出现了肿瘤再生的现象:我们报告了一例 40 岁亚洲女性患者的病例,在依维莫司上市之前,她曾接受分次立体定向放射治疗,成功治疗了生长期双侧独立下巨细胞星形细胞瘤。随访 8 年后,依维莫司被用于治疗肾血管脂肪瘤,患者随访至放疗后 13 年。连续的磁共振成像显示,放疗后体积缩小了80%,而使用依维莫司后体积缩小了90%。我们通过PubMed在Medline上进行了文献综述,建立了一个包含1298篇参考文献和780篇全文文章的数据库,以寻找独立绒毛膜下巨细胞星形细胞瘤放疗禁忌症的证据。共有13个病例描述了单次放射外科治疗的不同结果。只有两篇发表的文章提到了分次放射治疗的辐射剂量。有一篇文章提到了全脑放疗 8 年后诱发的继发性脑肿瘤:结论:没有证据表明分次放射治疗是治疗脐下巨细胞星形细胞瘤的禁忌症和排除症。我们的经验表明,独立乳突下巨细胞星形细胞瘤与其他颅内良性肿瘤一样,对放疗的反应缓慢但呈渐进性。
{"title":"Radiotherapy for subependymal giant cell astrocytoma: time to challenge a historical ban? A case report and review of the literature.","authors":"Randa Kamel, Dirk Van den Berge","doi":"10.1186/s13256-024-04649-2","DOIUrl":"10.1186/s13256-024-04649-2","url":null,"abstract":"<p><strong>Background: </strong>Subependymal giant cell astrocytoma is a benign brain tumor that occurs in patients with tuberous sclerosis complex. Surgical removal is the traditional treatment, and expert opinion is strongly against the use of radiotherapy. Recently, success has been reported with the mTor inhibitor everolimus in reducing tumor volume, but regrowth has been observed after dose reduction or cessation.</p><p><strong>Case report: </strong>We present the case of a 40-year-old Asian female patient treated successfully for growing bilateral subependymal giant cell astrocytoma with fractionated stereotactic radiotherapy before everolimus became available. After a follow-up of 8 years, everolimus was administered for renal angiomyolipoma and the patient was followed up until 13 years after radiotherapy. Successive magnetic resonance imaging demonstrated an 80% volume reduction after radiotherapy that increased to 90% with everolimus. A review of the literature was done leveraging Medline via PubMed, and we assembled a database of 1298 article references and 780 full-text articles in search of evidence for contraindicating radiotherapy in subependymal giant cell astrocytoma. Varying results of single-fraction radiosurgery were described in a total of 13 cases. Only in two published cases was the radiation dose of fractionated radiotherapy mentioned. One single publication mentions an induced secondary brain tumor 8 years after whole-brain radiotherapy.</p><p><strong>Conclusion: </strong>There is no evidence of contraindication and exclusion of fractionated radiotherapy in treating subependymal giant cell astrocytoma. Our experience demonstrates that subependymal giant cell astrocytoma, as other benign intracranial tumors, responds slowly but progressively to radiotherapy and suggests that fractionated stereotactic radiotherapy holds promise to consolidate responses obtained with mTor inhibitors avoiding regrowth after cessation.</p>","PeriodicalId":16236,"journal":{"name":"Journal of Medical Case Reports","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2024-07-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11264945/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141727223","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dengue rhabdomyolysis successfully treated with hemoperfusion using CytoSorb® in combination with continuous renal replacement therapy: a case report. 使用 CytoSorb® 结合持续肾脏替代疗法进行血液灌流成功治疗登革热横纹肌溶解症:病例报告。
IF 0.9 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-07-19 DOI: 10.1186/s13256-024-04661-6
Piyum Samarasingha, Harindra Karunatilake, Ananda Jayanaga, Hansani Jayawardhana, Dilshan Priyankara

Background: Dengue fever is a mosquito-borne viral infection with a broad spectrum of clinical manifestations. Expanded dengue syndrome includes unusual manifestations that do not fall into the categories of dengue fever, dengue hemorrhagic fever, or dengue shock syndrome. Rhabdomyolysis causing acute renal failure in dengue is one such unusual manifestation, the pathophysiology of which is incompletely understood.

Case presentation: We describe a 21-year-old Sri Lankan man with dengue fever who developed severe rhabdomyolysis and acute kidney injury with extremely high creatinine phosphokinase levels (> 2 million U/L). Management of this patient was challenging as his creatinine phosphokinase kept rising with persistent anuria despite hydration, intermittent hemodialysis, and, later, continuous venovenous hemodiafiltration. Further therapeutic options were explored, and CytoSorb® adsorber was added as an adjunct to continuous venovenous hemodiafiltration, following which we observed a marked reduction in his creatinine phosphokinase and myoglobin levels over the next 12 hours and complete renal recovery over the next 5 weeks.

Conclusion: We report a rare case of significant rhabdomyolysis secondary to dengue infection leading to acute kidney injury. Continuous venovenous hemodiafiltration performed with the hemofilter Pecopen 140 was ineffective, and the addition of CytoSorb® adsorber as an adjunct therapy to continuous venovenous hemodiafiltration may have a potential benefit in removing high-molecular-weight proteins such as myoglobin.

背景:登革热是一种由蚊子传播的病毒感染,具有广泛的临床表现。扩展登革热综合征包括不属于登革热、登革出血热或登革休克综合征范畴的异常表现。登革热引起急性肾功能衰竭的横纹肌溶解症就是这样一种不寻常的表现,其病理生理学尚不完全清楚:我们描述了一名 21 岁的斯里兰卡男性登革热患者,他出现了严重的横纹肌溶解症和急性肾损伤,肌酸磷酸激酶水平极高(> 200 万 U/L)。尽管进行了水合、间歇性血液透析以及后来的持续静脉血液透析,但患者的肌酸磷酸激酶仍持续上升,并伴有持续性无尿,因此对该患者的治疗极具挑战性。我们探索了进一步的治疗方案,并在持续静脉血液透析的基础上添加了 CytoSorb® 吸附剂,随后我们观察到他的肌酐磷酸激酶和肌红蛋白水平在接下来的 12 小时内明显下降,肾功能在接下来的 5 周内完全恢复:我们报告了一例罕见的登革热感染继发严重横纹肌溶解导致急性肾损伤的病例。使用血液滤过器Pecopen 140进行连续静脉血液透析效果不佳,而在连续静脉血液透析中添加CytoSorb®吸附器作为辅助疗法,可能有助于清除肌红蛋白等高分子量蛋白质。
{"title":"Dengue rhabdomyolysis successfully treated with hemoperfusion using CytoSorb® in combination with continuous renal replacement therapy: a case report.","authors":"Piyum Samarasingha, Harindra Karunatilake, Ananda Jayanaga, Hansani Jayawardhana, Dilshan Priyankara","doi":"10.1186/s13256-024-04661-6","DOIUrl":"10.1186/s13256-024-04661-6","url":null,"abstract":"<p><strong>Background: </strong>Dengue fever is a mosquito-borne viral infection with a broad spectrum of clinical manifestations. Expanded dengue syndrome includes unusual manifestations that do not fall into the categories of dengue fever, dengue hemorrhagic fever, or dengue shock syndrome. Rhabdomyolysis causing acute renal failure in dengue is one such unusual manifestation, the pathophysiology of which is incompletely understood.</p><p><strong>Case presentation: </strong>We describe a 21-year-old Sri Lankan man with dengue fever who developed severe rhabdomyolysis and acute kidney injury with extremely high creatinine phosphokinase levels (> 2 million U/L). Management of this patient was challenging as his creatinine phosphokinase kept rising with persistent anuria despite hydration, intermittent hemodialysis, and, later, continuous venovenous hemodiafiltration. Further therapeutic options were explored, and CytoSorb® adsorber was added as an adjunct to continuous venovenous hemodiafiltration, following which we observed a marked reduction in his creatinine phosphokinase and myoglobin levels over the next 12 hours and complete renal recovery over the next 5 weeks.</p><p><strong>Conclusion: </strong>We report a rare case of significant rhabdomyolysis secondary to dengue infection leading to acute kidney injury. Continuous venovenous hemodiafiltration performed with the hemofilter Pecopen 140 was ineffective, and the addition of CytoSorb® adsorber as an adjunct therapy to continuous venovenous hemodiafiltration may have a potential benefit in removing high-molecular-weight proteins such as myoglobin.</p>","PeriodicalId":16236,"journal":{"name":"Journal of Medical Case Reports","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2024-07-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11264817/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141723777","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Enzyme replacement therapy and immunotherapy lead to significant functional improvement in two children with Pompe disease: a case report. 酶替代疗法和免疫疗法使两名庞贝氏症患儿的功能显著改善:病例报告。
IF 0.9 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-07-18 DOI: 10.1186/s13256-024-04638-5
Sandra Milena Castellar-Leones, Fernando Ortiz-Corredor, Daniel Manrique-Hernández, Diana Sánchez-Peñarete, Edicson Ruiz-Ospina, Diana Soto-Peña, Cristian Correa-Arrieta

Background: Pompe disease, a rare autosomal recessive disorder caused by acid alpha-glucosidase deficiency, results in progressive glycogen accumulation and multisystem dysfunction. Enzyme replacement therapy with recombinant human acid alpha-glucosidase is the standard of care; however, some patients develop anti-recombinant human acid alpha-glucosidase antibodies, leading to reduced efficacy. This case report presents two infants with early-onset Pompe disease who developed IgG antibodies to enzyme replacement therapy and were subsequently treated with methotrexate, highlighting the importance of monitoring antibody development and exploring alternative therapeutic approaches.

Case presentation: Patient 1, a 10-month-old female from Bogota, Colombia, presented with generalized hypotonia, macroglossia, hyporeflexia, and mild left ventricular hypertrophy. Diagnostic tests confirmed early-onset Pompe disease, and enzyme replacement therapy was started at 12 months. Due to a lack of improvement and high anti-recombinant human acid alpha-glucosidase IgG antibody titers (1:1800), methotrexate was started at 18 months. After 8 months of combined therapy, antibody titers were negative and significant improvement in motor function was observed using the Gross Motor Function Measure 88. Patient 2, a 7-year-old female from Bogota, Colombia, was diagnosed with early-onset Pompe disease at 12 months and initiated enzyme replacement therapy. At 5 years of age, she experienced frequent falls and grip strength alterations. Functional tests revealed motor development delay, generalized hypotonia, and positive anti-recombinant human acid alpha-glucosidase IgG antibody titers (6400). Methotrexate was initiated, leading to a reduction in falls and antibody titers (3200) after 6 months, with no adverse events or complications. Motor function improvement was assessed using the Motor Function Measurement 32.

Conclusions: The presented cases highlight the importance of monitoring patients for anti-recombinant human acid alpha-glucosidase antibody development during enzyme replacement therapy and the potential benefit of methotrexate as an immunomodulatory agent in early-onset Pompe disease. Early diagnosis and timely initiation of enzyme replacement therapy, combined with prophylactic immune tolerance induction, may improve clinical outcomes and reduce the development of anti-recombinant human acid alpha-glucosidase antibodies. The cases also highlight the importance of objective motor function assessment tools, such as Gross Motor Function Measure 88 and Motor Function Measurement 32, in assessing treatment response. Further research is needed to optimize treatment regimens, monitor long-term effects, and address the current limitations of enzyme replacement therapy in Pompe disease.

背景:庞贝病是一种罕见的常染色体隐性遗传疾病,由酸性α-葡萄糖苷酶缺乏症引起,会导致进行性糖原累积和多系统功能障碍。使用重组人酸α-葡萄糖苷酶进行酶替代治疗是标准的治疗方法;然而,一些患者会产生抗重组人酸α-葡萄糖苷酶抗体,导致疗效降低。本病例报告介绍了两名早发型庞贝氏症婴儿,他们对酶替代疗法产生了 IgG 抗体,随后接受了甲氨蝶呤治疗,突出了监测抗体发展和探索替代疗法的重要性:患者 1 是一名 10 个月大的女性,来自哥伦比亚波哥大,出现全身肌张力低下、巨口症、反射减弱和轻度左心室肥大。诊断检查证实她患有早发型庞贝氏症,并在 12 个月时开始接受酶替代治疗。由于病情未见好转,且抗重组人酸α-葡萄糖苷酶 IgG 抗体滴度较高(1:1800),患者于 18 个月时开始接受甲氨蝶呤治疗。经过 8 个月的联合治疗后,抗体滴度转为阴性,而且根据 "运动功能测定 88"(Gross Motor Function Measure 88)观察到运动功能明显改善。患者 2 是一名来自哥伦比亚波哥大的 7 岁女性,在 12 个月大时被诊断为早发性庞贝氏症,并开始接受酶替代疗法。5 岁时,她经常摔倒并出现握力改变。功能测试显示她运动发育迟缓、全身肌张力低下,抗重组人酸α-葡萄糖苷酶 IgG 抗体滴度呈阳性(6400)。开始使用甲氨蝶呤治疗,6个月后,跌倒次数和抗体滴度(3200)均有所下降,且未出现不良反应或并发症。运动功能改善情况通过运动功能测量 32 进行评估:上述病例强调了在酶替代疗法期间监测患者抗重组人酸α-葡萄糖苷酶抗体发展的重要性,以及甲氨蝶呤作为免疫调节剂对早发庞贝氏症的潜在益处。早期诊断和及时启动酶替代疗法,结合预防性免疫耐受诱导,可以改善临床疗效,减少抗重组人酸α-葡萄糖苷酶抗体的产生。这些病例还强调了客观运动功能评估工具(如粗大运动功能测量88和运动功能测量32)在评估治疗反应方面的重要性。还需要进一步的研究来优化治疗方案、监测长期疗效并解决庞贝氏症酶替代疗法目前存在的局限性。
{"title":"Enzyme replacement therapy and immunotherapy lead to significant functional improvement in two children with Pompe disease: a case report.","authors":"Sandra Milena Castellar-Leones, Fernando Ortiz-Corredor, Daniel Manrique-Hernández, Diana Sánchez-Peñarete, Edicson Ruiz-Ospina, Diana Soto-Peña, Cristian Correa-Arrieta","doi":"10.1186/s13256-024-04638-5","DOIUrl":"10.1186/s13256-024-04638-5","url":null,"abstract":"<p><strong>Background: </strong>Pompe disease, a rare autosomal recessive disorder caused by acid alpha-glucosidase deficiency, results in progressive glycogen accumulation and multisystem dysfunction. Enzyme replacement therapy with recombinant human acid alpha-glucosidase is the standard of care; however, some patients develop anti-recombinant human acid alpha-glucosidase antibodies, leading to reduced efficacy. This case report presents two infants with early-onset Pompe disease who developed IgG antibodies to enzyme replacement therapy and were subsequently treated with methotrexate, highlighting the importance of monitoring antibody development and exploring alternative therapeutic approaches.</p><p><strong>Case presentation: </strong>Patient 1, a 10-month-old female from Bogota, Colombia, presented with generalized hypotonia, macroglossia, hyporeflexia, and mild left ventricular hypertrophy. Diagnostic tests confirmed early-onset Pompe disease, and enzyme replacement therapy was started at 12 months. Due to a lack of improvement and high anti-recombinant human acid alpha-glucosidase IgG antibody titers (1:1800), methotrexate was started at 18 months. After 8 months of combined therapy, antibody titers were negative and significant improvement in motor function was observed using the Gross Motor Function Measure 88. Patient 2, a 7-year-old female from Bogota, Colombia, was diagnosed with early-onset Pompe disease at 12 months and initiated enzyme replacement therapy. At 5 years of age, she experienced frequent falls and grip strength alterations. Functional tests revealed motor development delay, generalized hypotonia, and positive anti-recombinant human acid alpha-glucosidase IgG antibody titers (6400). Methotrexate was initiated, leading to a reduction in falls and antibody titers (3200) after 6 months, with no adverse events or complications. Motor function improvement was assessed using the Motor Function Measurement 32.</p><p><strong>Conclusions: </strong>The presented cases highlight the importance of monitoring patients for anti-recombinant human acid alpha-glucosidase antibody development during enzyme replacement therapy and the potential benefit of methotrexate as an immunomodulatory agent in early-onset Pompe disease. Early diagnosis and timely initiation of enzyme replacement therapy, combined with prophylactic immune tolerance induction, may improve clinical outcomes and reduce the development of anti-recombinant human acid alpha-glucosidase antibodies. The cases also highlight the importance of objective motor function assessment tools, such as Gross Motor Function Measure 88 and Motor Function Measurement 32, in assessing treatment response. Further research is needed to optimize treatment regimens, monitor long-term effects, and address the current limitations of enzyme replacement therapy in Pompe disease.</p>","PeriodicalId":16236,"journal":{"name":"Journal of Medical Case Reports","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2024-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11256466/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141633699","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Medical Case Reports
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1